ClinicalTrials.gg
RecruitingNCT07057453BE FIT 24Updated Nov 4, 2026

National Childhood Obesity Prevention Programme BE FIT 24

An interventional study of Motivation Engagement for Movement and Interactive Nutrition Development in Childhood Obesity, sponsored by Institute of Health Information and Statistics of the Czech Republic. Recruiting at 1 site in Czechia. Open to participants aged 6 Years to 11 Years. Per ClinicalTrials.gov, last updated 2026-11-04.

Sponsored by Institute of Health Information and Statistics of the Czech Republic · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Registered 6 months after the study started (first participant enrolled Nov 2024, registered May 2025).
  • Started Nov 2024; still recruiting 2 years later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
1,000
Allocation
Not applicable
Ages
6 Years to 11 Years
Sex
All
01

Study summary

The project is a national, prospective, multicenter, interventional pilot project of early detection of childhood overweight and the prevention of obesity in the Czech Republic.

The main goal of the project is to methodically prepare, implement and evaluate a pilot project that will verify the suitability of the proposed procedure of early detection of childhood overweight and the prevention of obesity and setting up and testing new methods and implementation into the system of health care.

Read the detailed description

The project is a national, prospective, multicenter, interventional pilot project of early detection of childhood overweight and the prevention of obesity in the Czech Republic.

The aim of the project is to prepare and test innovative tools for optimization of health parameters in childhood, including the preparation of a general health prevention program for obesity as one of the main predeterminants of negative health development in the child population. The primary measurable clinical goal of the project is a 5% reduction in Body mass index (BMI) in children after completing the one-year program.

The project will engage approximately 1,000 overweight children aged 6-11 years in an innovative, gamified experience promoting a healthy lifestyle. Each child will receive a fitness bracelet to monitor their physical activity, while a fun, interactive mobile app will motivate them through challenges and games to maintain a balanced energy level. Additionally, the whole family will benefit from educational resources on a web portal, encouraging a playful and supportive approach to adopting healthier habits together.

The project is supported by the European Social Fund (Operational Program Employment plus) and the state budget of the Czech Republic and is registered by the Ministry of Labour and Social Affairs of the Czech Republic under ID: CZ.03.02.02/00/22_005/0003842.

Study is conducted at approximately 100 sites across Czechia. For a complete list of study sites, please contact the overall study coordinator.

02

Conditions studied

  • Childhood Obesity

Keywords

  • Early detection
  • Overweight
  • Fitness bracelets
03

In context

Pediatric Obesity

1,132 studies on the registry are indexed under Pediatric Obesity; 183 are open to participants now.

This study's planned enrollment of 1,000 is above the median of 100 across 872 interventional studies indexed under Pediatric Obesity.

Browse Pediatric Obesity studies →

Lead sponsor

Institute of Health Information and Statistics of the Czech Republic is the lead sponsor of 14 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 11 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age: 6-11 years
  • : Between the 90th and 97th percentile
  • Signed consent to participate in the project and GDPR

Exclusion criteria

Exclusion Criteria:

  • Children with a between the 90th and 97th percentile with an associated chronic disease requiring continuous pharmacological treatment
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
1,000 participants (estimated)

Study arms

  • Other
    Overweight Children

    Overweight children aged 6-11 years who will receive a fitness bracelet and use a gamified mobile app to encourage physical activity and healthy habits through interactive challenges and rewards.

    Other: Motivation Engagement for Movement and Interactive Nutrition Development

Interventions

  • OtherMotivation Engagement for Movement and Interactive Nutrition Development

    The intervention includes using of fitness bracelets, a gamified mobile app, a web portal, and regular pediatric check-ups to support healthy habits in overweight children (6-11 years). The bracelets track physical activity, while the mobile app monitors energy balance, encouraging movement and healthy eating through challenges and rewards. The web portal provides family education, and pediatric check-ups track progress and overall health outcomes.

06

What researchers measure

Primary outcomes

  1. Mean percentage change in BMI of children over the intervention period

    Time frame: Up to 1 year from enrollment

Secondary outcomes

  1. Changes in BMI by subgroups of children (by gender, age, region, with/without playmate)

    Time frame: Up to 1 year from enrollment

  2. Evaluation of energy expenditure (kilojoules) measured using a fitness bracelet during the competition weeks.

    Time frame: Up to 1 year from enrollment

  3. Proportion of children who completed the full process (one-year participation in the program)

    Time frame: Up to 1 year from enrollment

07

Study locations

1 of 1 sites recruiting
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Nov 2024 to primary completion in Jun 2026, 19 months.

Of 542 non-industry interventional studies with no phase under Pediatric Obesity, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 45. This study's 19 months is below that.

Counting every sponsor, half of 544 studies reached it within 25 months; a quarter within 11 and three quarters within 45.

How these figures are worked out, and which studies are left out of them.

Registered
May 23, 2025
First posted
Jul 9, 2025
StartActual
Nov 19, 2024
Primary completionActual
Jun 30, 2026
CompletionEst.
Dec 31, 2026
Last update
Nov 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Minor edits
Nothing that changes what the study is or who can join. Edited: verification date, date precision and oversight details
1 update, last Nov 4, 2026
Show all 1 update
  1. Nov 4, 2026
    Minor edits only
    + 3 other changes: verification date, date precision and oversight details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07057453
Lead sponsor
Institute of Health Information and Statistics of the Czech Republic
Collaborators
Czech Technical University in Prague, STOB CZ s.r.o., Charles University, Czech Republic, Ceska Lekarska Spolecnost Jana Evangelisty Purkyne z.s., Czech Medical Chamber
Responsible party
Sponsor
First posted
Jul 9, 2025
Start date
Nov 19, 2024
Primary completion
Jun 30, 2026
Completion
Dec 31, 2026 (estimated)
Last update
Nov 4, 2026

Study contacts

Michal Hink, Msc
Contact
michal.hink@uzis.cz
771270565
Lucie Mandelová, PhD
Contact
lucie.mandelova@uzis.cz
Petr Jehlička, PhD
study director · Pediatric Cardiology, Plzeň, Czech Republic

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion